Poe Brandon
POE BRANDON, CFO, reported a transaction classified as exercise at BioStem Technologies, Inc. involving 10634.000000 shares for an estimated $0.00. Reported holdings after the transaction were 56368.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 11, 2026
- Filing date
- Aug 20, 2026
How reported position traded is calculated
Calculated only for code-P purchases and code-S sales.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingBSEM price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- exercise Code M
- Identifier
- 0002147189-26-000006 Common Stock
- Transaction date
- Aug 11, 2026 Filed Aug 20, 2026, 11:30 PM · 9d delay
- Shares
- 10,634 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 56,368 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
0 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - delayed_filing-6 points
reporting_delay_days = 9
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Financial Officer
- F1
These options vest according to the following schedule: 33% vested on August 11, 2026, with the remaining options vesting in equal quarterly installments over the subsequent two year period.
- F2
These options vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installmen…
- F3
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F4
These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).
- F5
These restricted stock units vest according to the following schedule: 33% vested on August 11, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year peri…
- F6
These restricted stock units vest according to the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarter…
0 other transactions
0 recent txs